Vertex Pharma Acquires ViroChem For $395M
Vertex completed the share purchase transaction on Thursday, according to a press release. ViroChem shareholders received $100 million in cash and 10.73 million shares of Vertex common stock, the company said.
Vertex stock was trading at $27.15 per share on March 11, the company disclosed in a filing with the U.S. Securities and Exchange Commission on...
To view the full article, register now.